Calmodulin kinase II accelerates L-type Ca2+ current recovery from inactivation and compensates for the direct inhibitory effect of [Ca2+]i in rat ventricular myocytes

J Physiol. 2006 Jul 15;574(Pt 2):509-18. doi: 10.1113/jphysiol.2006.109199. Epub 2006 Apr 20.

Abstract

Some studies report that the positive relationship between L-type Ca(2+) current (I(Ca-L)) and frequency in cardiac myocytes is mainly due to a direct negative feedback of sarcoplasmic reticulum Ca(2+) release on I(Ca-L) inactivation while others provide evidence for activation of calmodulin kinase II (CaMKII). To further elucidate the role of endogenous CaMKII activity, the CaMKII inhibitory peptides, autocamtide-2 relating inhibitory peptide (AIP) and myristoylated AIP were applied using conventional and perforated patch-clamp methods. AIP inhibited the normal adaptive increase in I(Ca-L) in response to abrupt increase in pacing frequency from 0.05 to 2 Hz. The positive I(Ca-L)-frequency relationship was reversed by AIP and the inhibitory effect of AIP was significantly exaggerated at fast pacing rates. The onset of inactivation of I(Ca-L) was not altered by AIP. After thapsigargin treatment, AIP slowed recovery from inactivation of I(Ca-L) and this effect was exaggerated during fast pacing. Buffering of [Ca(2+)](i) by BAPTA and EGTA accelerated recovery of I(Ca-L) from inactivation, and BAPTA partly eliminated the effect of AIP on the recovery. We conclude that: (1) [Ca(2+)](i) directly slows I(Ca-L) recovery from inactivation; and (2) Ca(2+)-dependent endogenous CaMKII activity accelerates the I(Ca-L) recovery. Thus, at fast heart rates, elevated [Ca(2+)](i) activates endogenous CaMKII and compensates for its direct inhibitory effect on I(Ca-L) recovery from inactivation. Dynamic activity of endogenous CaMKII enhances the positive I(Ca-L)-frequency relationship.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcium / physiology*
  • Calcium Channels, L-Type / drug effects
  • Calcium Channels, L-Type / physiology*
  • Calcium-Calmodulin-Dependent Protein Kinases / physiology*
  • Chelating Agents / pharmacology
  • Egtazic Acid / analogs & derivatives
  • Egtazic Acid / pharmacology
  • Enzyme Activation / drug effects
  • Enzyme Activation / physiology
  • Enzyme Inhibitors / pharmacology
  • Feedback, Physiological / physiology
  • Male
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / enzymology
  • Myocytes, Cardiac / physiology*
  • Patch-Clamp Techniques
  • Peptides / pharmacology
  • Rats
  • Rats, Inbred Strains
  • Sarcoplasmic Reticulum / physiology
  • Thapsigargin / pharmacology

Substances

  • CaMKII inhibitor AIP
  • Calcium Channels, L-Type
  • Chelating Agents
  • Enzyme Inhibitors
  • Peptides
  • myristoylated autocamtide-2-related inhibitory peptide
  • Egtazic Acid
  • Thapsigargin
  • Calcium-Calmodulin-Dependent Protein Kinases
  • 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid
  • Calcium